Clinical Trials · NCT01473602

Second Study of the Effect of Teriparatide on Hip Fracture Healing

CompletedPhase 3Teriparatide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
39
Start date
Jan 2012
Locations
75 sites, 14 countries
Primary endpoint
Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture
View Teriparatide compound reference